Quarterly report pursuant to Section 13 or 15(d)

CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY

v3.21.1
CONDENSED STATEMENTS OF STOCKHOLDERS' EQUITY - USD ($)
Common Stock
Additional Paid-in Capital
Accumulated Deficit
Total
Balance at Dec. 31, 2019 $ 57,000 $ 561,000 $ (238,000) $ 380,000
Balance (in Shares) at Dec. 31, 2019 57,505,208      
Share-based compensation $ 0 64,000 0 64,000
Issuance of common stock $ 16,000 604,000 0 620,000
Issuance of common stock (in shares) 15,500,000      
Net loss $ 0 0 (508,000) (508,000)
Balance at Mar. 31, 2020 $ 73,000 1,229,000 (746,000) 556,000
Balance (in Shares) at Mar. 31, 2020 73,005,208      
Balance at Dec. 31, 2020 $ 99,000 2,474,000 (2,502,000) 71,000
Balance (in Shares) at Dec. 31, 2020 99,331,279      
Share-based compensation   69,000   69,000
Restricted stock vesting   21,000   21,000
Restricted stock vesting (in shares) 0      
Issuance of common stock $ 4,000 281,000   285,000
Issuance of common stock (in shares) 3,563,000,000      
Warrants issued for equity raising costs $ 0 (18,000) 0 (18,000)
Beneficial conversion and warrant features of convertible debt 0 1,276,000 0 1,276,000
Net loss     (704,000) (704,000)
Balance at Mar. 31, 2021 $ 103,000 $ 4,103,000 $ (3,206,000) $ 1,000,000
Balance (in Shares) at Mar. 31, 2021 102,894,279